Chemotherapy use near the end-of-life in patients with metastatic breast cancer

Introduction Very few data are available regarding the use of chemotherapy in patients with metastatic breast cancer (MBC) near the end-of-life, i.e., the final month. The aim of this study was to provide a descriptive analysis of its use in two different European geographic areas (Sweden and Greece...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Breast cancer research and treatment 2020-06, Vol.181 (3), p.645-651
Hauptverfasser:	Edman Kessler, Luisa, Sigfridsson, Johnny, Hatzidaki, Dora, Bergh, Jonas, Foukakis, Theodoros, Georgoulias, Vasilios, Matikas, Alexios
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Analysis Antineoplastic Combined Chemotherapy Protocols - therapeutic use Breast cancer Breast Neoplasms - drug therapy Breast Neoplasms - pathology Cancer Cancer patients Cancer research Carcinoma, Ductal, Breast - drug therapy Carcinoma, Ductal, Breast - secondary Carcinoma, Lobular - drug therapy Carcinoma, Lobular - secondary Chemotherapy Clinical Trial Death Drug therapy, Combination Female Follow-Up Studies Health aspects Hospitals Humans Intravenous administration Medicin och hälsovetenskap Medicine Medicine & Public Health Metastases Metastasis Middle Aged Oncology Patients Prognosis Quality of life Receptor, ErbB-2 - metabolism Receptors, Estrogen - metabolism Receptors, Progesterone - metabolism Retrospective Studies Survival Survival Rate Vinorelbine Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!